Articles Tagged With:
-
ED Push - June 2016 First Issue
-
Treatment Selection for Older Adults with Atrial Fibrillation
The diversity of choices now requires closer attention to individual patient characteristics and preferences to ensure best outcomes.
-
Sublingual Desensitization Against House Dust Mites
Sublingual house dust mite desensitization is a promising tool for asthmatic patients not well controlled on inhaled steroids.
-
Updated Guidelines on Acne Management
The new guidelines provide a useful template on which to plan management of acne at all levels of severity.
-
Long-acting Anticholinergics and Beta Agonists for COPD
Combining long-acting antimuscarinic agents with long-acting beta-agonists provides meaningfully better symptomatic improvement than either agent alone.
-
Liraglutide Improves Non-alcoholic Steatohepatitis
In a recently published paper, the number of study subjects who attained resolution of non-alcoholic steatohepatitis was more than four-fold greater in a liraglutide group than those on placebo.
-
Improving Sexual Function and Mood
In a recent trial, testosterone replacement resulted in statistically significant improvements in sexual function, desire, mood, and depression.
-
Screening for Ovarian Cancer: Helpful or Harmful?
Ovarian cancer has the highest mortality of any of the gynecologic cancers. Due to the poor prognosis associated with this disease, researchers have been searching for 50 years for an early detection tool.
-
A Low-Dose Estrogen Capsule Examined as Possibility for Vaginal Atrophy
About 32 million postmenopausal women in the United States are affected by vulvar and vaginal atrophy, which can cause painful sexual activity and urination, as well as vaginal dryness, itching, and irritation. Recent data presented at ENDO 2016, the annual meeting of the Endocrine Society, suggests an investigational low-dose vaginal estrogen capsule may help relieve such symptoms.
-
Medicaid Pushes Forward on Family Planning
With the end of the Obama administration rapidly approaching, federal agencies have stepped up their efforts to finalize long-brewing regulations and guidance. CMS has been particularly active. In April 2016, the agency issued three documents that all have considerable importance for family planning services and providers under Medicaid.